CLINICAL_TRIALS
trial_result
· 2018-06-04
Clinical Trial Update: Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis [Phase 3]
Summary
Phase 3 trial update evaluating the efficacy and safety of IBI303 in adults with active ankylosing spondylitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: AS | Phase 3 | Status: COMPLETED